The right flank tumor was then injected with 30μg of the TLR9 agonist ODN1826 or PBS on days 3, 6 and 9 with or without concordant injection of 100μg of the CTLA-4 blocking antibody 9H10 systemically. The gene discussed is TLR9; the disease is neoplasm.